Safety and Efficacy of BARS13 in the Elderly

Clinical trial NCT04681833 · COMPLETED

Trial details

NCT number: NCT04681833
Sponsor: Advaccine (Suzhou) Biopharmaceuticals Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infections

Start date: 2021-05-24
Primary completion: 2024-01-26
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.